How many drugs treat Muscle Spasm with Pain?

Drug Landscape tracks 4 marketed treatments for Muscle Spasm with Pain (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/muscle-spasm-with-pain.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Muscle Spasm with Pain — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Muscle Spasm with Pain (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Muscle Spasm with Pain, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Soma	CARISOPRODOL	Mylan Speciality Lp	Muscle Relaxant [EPC]		1959-01-01
Parafon Forte Dsc	CHLORZOXAZONE	Johnson & Johnson	Muscle Relaxant [EPC]	Nitric oxide synthase, endothelial	1958-01-01
Robaxin	METHOCARBAMOL	Hikma	Muscle Relaxant [EPC]	Carbonic anhydrase 1	1957-01-01
Codeine	codeine phosphate	Generic (multiple manufacturers)	Opioid analgesic, Antitussive	Delta-type opioid receptor, Kappa-type opioid receptor, Mu-type opioid receptor	1950-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Generic (multiple manufacturers) · 1 drug in Muscle Spasm with Pain
Hikma · 1 drug in Muscle Spasm with Pain
Johnson & Johnson · 1 drug in Muscle Spasm with Pain
Mylan Speciality Lp · 1 drug in Muscle Spasm with Pain

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Muscle Spasm with Pain:

Cite this brief

Drug Landscape (2026). Muscle Spasm with Pain — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/muscle-spasm-with-pain. Accessed 2026-06-10.

Muscle Spasm with Pain full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing